Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Ovarian Cancer
Clinical Trials
Non-Small Cell Lung Cancer
Immunotherapy
Biliary Tract Cancers
PARP Inhibitors
Chronic Lymphocytic Leukemia
Myelofibrosis
Antibody-Drug Conjugates
Gastroesophageal Cancers
Bevacizumab
Ruxolitinib
Lung Cancer
Acute Myeloid Leukemia
Myelodysplastic Syndromes
CA125
Palabresib
Gynecologic Oncology
Hepatobiliary Cancers
BTK Inhibitors

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes387Founded6 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT i... more

Ms Jaime Carroll from Mayo Clinic in Rochester, Minnesota, Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy, Dr Marie E McDonnell from Brigham and Women’s Hospital in Boston, Massachusetts, and Dr Hope S Rugo from... more

YouTube

Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medi... more

YouTube

Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical finding... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr. Ravin Ratan
From the MD Anderson Cancer Center in Houston
MD Anderson Cancer Center, Houston
Episode: Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Dr Bijal Shah
Medical oncologist at Moffitt Cancer Center
Moffitt Cancer Center
Episode: CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
Constantine Tam
Professor, Monash University
Monash University, Melbourne, Australia
Episode: Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Nicoletta Colombo
Faculty presenter from European Institute of Oncology
European Institute of Oncology, Milan
Episode: Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Katie Moore
Faculty presenter from Fred and Pamela Buffett Cancer Center
University of Nebraska Omaha, Fred and Pamela Buffett Cancer Center
Episode: Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Christopher Lieu
Oncologist at University of Colorado Cancer Center
University of Colorado Cancer Center
Episode: Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis
Hanny Al-Samkari
Medical oncologist discussing ASH 2025 key papers on ITP
Massachusetts General Hospital
Episode: Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
Hope Rugo
Dr Hope Rugo, City of Hope Comprehensive Cancer Center
City of Hope Comprehensive Cancer Center
Episode: Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Sara Tolaney
Dr Sara Tolaney, Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Host

Dr Neil Love
Medical oncologist specializing in oncology practice and research.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#119
Saudi Arabia/Science
Apple Podcasts
#158
Hong Kong/Science

Talking Points

Recent interactions between the hosts and their guests.

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
Q: How do the newer agents like Servatimig and MK1045 differ from Blenatumumab in design and safety?
Servatimig is a fully human bispecific with an FC-silenced stalk to reduce prolonged toxicity and a low-affinity CD3 binder, leading to lower rates of CRS; MK1045 resembles a more conventional antibody structure with a silenced Fc and shows very low grade CRS/ICANNs in early trials.
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
Q: What is the clinical significance of Blenatumumab's transition from salvage to frontline therapy in ALL?
It shifted the treatment paradigm by improving cure potential and lowering relapse-related mortality, especially when used in MRD-guided frontline settings, while also reducing some chemotherapy-related toxicity.
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
Q: What is the expected role of VEHIT-1 in the treatment landscape for ITP, and how does it compare to VEHIT-2 in terms of patient selection and endpoints?
VEHIT-1 targets a broad primary ITP population, excluding only HIV- or CLL-induced cases, and aims to answer whether a shorter treatment course can achieve durable responses, potentially lowering steroid exposure compared with prior approaches.
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Q: Could you review the initial efficacy data in terms of response rate and duration of responses?
The DEFY publication reported a 41% response rate with Niragasostat versus 8% with placebo, and there was an observation of ongoing responses in some patients, including deepening responses over time, though durability and the necessity of continued treatment remained to be fully defined.
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Q: What is the stance on MRD as an endpoint for regulatory approval?
MRD is being considered a valuable endpoint in some diseases, with FDA precedent in myeloma, but in CLL the acceptance is not uniform and depends on the context of MRD assessment in blood versus bone marrow and co-administered antibodies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Content focuses primarily on the latest advancements in oncology, featuring in-depth discussions between a medical oncologist and clinical investigators. Key topics include treatment protocols for various cancers, insights from recent clinical trials, and expert commentary on emerging therapies and practices. Noteworthy is the emphasis on personalized treatment strategies and the evolving landscape of therapies across multiple oncology domains, including bladder, prostate, and gynecologic cancers. Episodes highlight significant findings from major conferences that guide current clinical practices, making it a valuable resource for healthcare professionals seeking to stay updated on oncology innovations.

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. Hematologic Oncology Update

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 387 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Dr. Ravin Ratan
2. Dr Bijal Shah
3. Constantine Tam
4. Nicoletta Colombo
5. Katie Moore
6. Christopher Lieu
7. Hanny Al-Samkari
8. Hope Rugo

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days